Coronin1A regulates tumor microenvironment in colitis-associated colorectal cancer in a SUMO-dependent way

This study reveals that Coronin1A, stabilized by SUMOylation via SENP5 and Raftlin, drives colitis-associated colorectal cancer by regulating TGF-β signaling endosome stability to promote M2-like macrophage polarization and a pro-tumorigenic tumor microenvironment.

The Gist

The Big Picture: From a Burn to a Fire

Imagine your gut (intestines) as a busy city. Sometimes, due to a condition like Ulcerative Colitis, the city gets into a state of constant civil unrest (chronic inflammation). The police (immune cells) are constantly fighting fires and repairing damage.

Usually, if the fires are put out, the city goes back to normal. But in some people, this constant chaos creates a "perfect storm" where bad neighborhoods start forming, eventually turning into a colorectal cancer (a tumor). This specific type of cancer is called Colitis-Associated Colorectal Cancer (CAC).

Scientists have known that inflammation leads to cancer, but they didn't fully understand how the city's security forces (immune cells) accidentally help build the criminal gangs (tumors) instead of stopping them. This paper solves that mystery.

---

The Main Characters

1. The City (The Gut): The place where everything happens.
2. The Police (Macrophages): Immune cells that patrol the gut. They have two modes:
   • Mode A (The Good Cop): They fight infection and clean up trash.
   • Mode B (The Corrupt Cop / M2 Macrophage): They stop fighting and start helping the bad guys build a fortress. This is the "tumor-friendly" mode.
3. Coro1A (The Foreman): A protein found inside the police cells. Think of him as the Foreman who tells the police how to behave.
4. SENP5 (The Manager): A protein that manages the Foreman.
5. SUMO (The ID Badge): A tiny tag that gets stuck onto proteins to change how they work.
6. Raftlin (The Delivery Truck): A protein that carries important signals.

---

The Story Unfolds

1. The Mystery of the "Corrupt" Foreman

The researchers looked at mice with chronic gut inflammation and found that their "Foreman" (Coro1A) was acting strangely.

• In a healthy gut: The Foreman is quiet.
• In an inflamed gut: The Foreman goes into overdrive. He starts telling the police (macrophages) to switch to Mode B (the Corrupt Cop). Instead of fighting, the police start building a protective wall around the bad cells, helping them grow into tumors.

The Analogy: Imagine the Foreman (Coro1A) is a construction manager. In a healthy city, he manages repairs. But in a chaotic city, he starts building a fortress around the criminals, protecting them from the law.

2. The "Missing Manager" (SENP5)

The scientists noticed something weird about the Foreman's boss, SENP5.

• In Sporadic Cancer (cancer that happens without inflammation), the boss is working overtime, trying to fix things.
• In Colitis-Associated Cancer (cancer caused by inflammation), the boss (SENP5) actually disappears from the tumor area.

When the boss is gone, the Foreman (Coro1A) gets confused and starts interacting with the wrong people. He grabs onto a delivery truck called Raftlin that has a special "ID Badge" (SUMO) stuck to it.

3. The "ID Badge" Connection (SUMOylation)

Here is the tricky part made simple:

• The delivery truck (Raftlin) gets an ID Badge (SUMO) attached to it.
• The Foreman (Coro1A) has a special hook on his belt called a SIM (SUMO-Interacting Motif).
• The Foreman grabs the ID Badge on the truck. This connection is the key.

Without this connection, the Foreman falls apart and disappears. But when he holds onto the ID-badge-wearing truck, he becomes super strong and stable. He then runs to the police station and tells them: "Stop fighting! Start building a fortress for the tumor!"

4. The "TGF-β" Signal (The Order)

The Foreman (Coro1A) has another job: he protects a specific signal called TGF-β.

• Think of TGF-β as a radio signal telling the police to stand down and help the tumor.
• Normally, this signal gets destroyed by the cell's garbage disposal (lysosomes).
• But the Foreman (Coro1A) uses a calcium-powered shield (Calcineurin pathway) to protect the radio signal from being thrown away.
• Because the signal is protected, the police stay in "Corrupt Mode" (M2), helping the tumor grow.

---

The Experiment: What Happens Without the Foreman?

The scientists created a group of mice that were missing the Foreman (Coro1A).

• Normal Mice: When given chemicals to induce inflammation, they got sick, developed polyps (pre-cancerous growths), and grew tumors. Their immune system helped the cancer.
• Foreman-Deficient Mice: When given the same chemicals, they still got a little bit of inflammation, but they did NOT get tumors.
  • Their immune cells didn't switch to "Corrupt Mode."
  • The "fortress" around the bad cells wasn't built.
  • The cancer couldn't take hold.

The Takeaway (The "So What?")

This paper discovers a new switch that turns a healthy immune response into a cancer-promoting one.

1. Inflammation changes the gut environment.
2. A protein called SENP5 changes its behavior, leading to a buildup of SUMOylated Raftlin.
3. This attracts the Foreman (Coro1A).
4. The Foreman stabilizes the TGF-β signal, which tells immune cells to stop fighting and start helping the cancer.
5. If you remove the Foreman, the cancer cannot grow, even if the inflammation is there.

Why does this matter?
It suggests that if we can find a drug to block the Foreman (Coro1A) or stop him from grabbing the ID-badge-wearing truck, we might be able to stop inflammation from turning into cancer. It's like firing the corrupt construction manager so he can't build the fortress for the criminals.

Summary in One Sentence

The study found that a specific protein (Coro1A) acts like a corrupt foreman in inflamed guts; it grabs onto a tagged delivery truck to protect a "stop fighting" signal, which tricks the immune system into helping cancer grow, and removing this foreman stops the cancer from forming.

Technical Summary

1. Problem Statement

Colitis-associated colorectal cancer (CAC) is a severe complication of Inflammatory Bowel Disease (IBD), characterized by a transition from chronic inflammation to dysplasia and carcinoma. While the role of chronic inflammation is well-established, the specific molecular mechanisms driving the reprogramming of the tumor microenvironment (TME) from an inflammatory state to a pro-tumorigenic, immunosuppressive state remain elusive. Specifically, the role of post-translational modifications (PTMs), particularly SUMOylation, and the specific immune cell regulators involved in CAC progression are underexplored compared to sporadic colorectal cancer (SCRC).

2. Methodology

The study employed a multi-faceted approach combining in vivo mouse models, human clinical samples, and in vitro mechanistic studies:

• Animal Models:
  • AOM-DSS Model: Used to induce CAC in Wild-Type (WT) and Coro1A Knockout (KO) mice.
  • IL-10⁻/⁻ Model: Used to validate findings in a genetic model of spontaneous colitis.
  • Apc⁺/⁻ Model: Used to model Sporadic Colorectal Cancer (SCRC) for comparative analysis.
• Human Samples: Biopsies from patients with CAC, SCRC, Ulcerative Colitis (UC), and Irritable Bowel Syndrome (IBS) were analyzed.
• Omics & Proteomics:
  • Interactome Analysis: Co-immunoprecipitation (Co-IP) of SENP5 followed by Mass Spectrometry (MS/MS) to identify binding partners in different disease states (Control, Chronic Colitis, Non-polyp, Polyp).
  • SUMOylome Profiling: Western blotting to assess global SUMO1 and SUMO2/3 conjugation levels.
• Cell Biology & Molecular Mechanisms:
  • Cell Lines: RAW264.7 and J774 macrophages (WT and Coro1A KD).
  • Techniques: Co-IP, Structured Illumination Microscopy (SIM), Flow Cytometry (immune phenotyping), qRT-PCR, ELISA, and Immunofluorescence.
  • Computational: Molecular docking (HADDOCK), Molecular Dynamics simulations (CABS-Flex), and SIM site prediction (GPS-SUMO, JASSA).
• Pharmacological Interventions: Use of inhibitors (Bafilomycin-A1, MG-132, BAPTA-AM, Cyclosporin A, FK506) to dissect degradation pathways and signaling cascades.

3. Key Contributions & Findings

A. Differential Regulation of SENP5 in CAC vs. SCRC

• Observation: The deSUMOylase SENP5 exhibits a distinct expression pattern in CAC compared to SCRC.
• CAC: SENP5 is upregulated in chronically inflamed (non-polyp) tissue but downregulated in polyp/tumor regions.
• SCRC: SENP5 is upregulated in polyp/tumor regions.
• Significance: This suggests a unique role for SENP5 and the SUMOylation machinery in the inflammation-to-cancer transition specific to IBD.

B. Identification of Coronin1A (Coro1A) as a Critical Interactor

• Interactome Shift: SENP5 interactome analysis revealed a shift in binding partners. In non-polyp/chronic inflammation regions, SENP5 strongly interacts with actin-binding proteins, specifically Coronin1A (Coro1A). This interaction is lost in polyp regions.
• Expression Dynamics: Coro1A is significantly upregulated in chronic colitis and the non-polyp adjacent tissue of CAC (driven by infiltrating immune cells), but its expression drops in the polyp/tumor core.
• Functional Necessity: Coro1A KO mice were resistant to CAC development. They showed:
  • Reduced polyp formation and adenocarcinoma.
  • Attenuated cell proliferation (Ki-67, C-Myc).
  • Reduced Epithelial-to-Mesenchymal Transition (EMT) and fibrosis (ECM markers like Fibronectin, $\alpha$-SMA).
  • Lower levels of M2-like macrophages.

C. Mechanism: Coro1A Drives M2 Macrophage Polarization via TGF-$\beta$

• Macrophage Link: High Coro1A expression correlates with M2-like (Arg1+) macrophages, which are pro-tumorigenic.
• Direct Interaction: Coro1A physically interacts with TGF-$\beta$ Receptor I (TGF-$\beta$RI).
• Signaling Stability:
  • In the absence of Coro1A, TGF-$\beta$RI levels decrease, leading to impaired TGF-$\beta$ signaling (reduced pSMAD3 nuclear accumulation).
  • Degradation Pathway: Coro1A protects the TGF-$\beta$RI signaling endosome from lysosomal degradation. Without Coro1A, the receptor is targeted to lysosomes.
  • Calcium-Calcineurin Axis: Coro1A utilizes a calcium-calcineurin signaling pathway to stabilize these endosomes. Chelating calcium (BAPTA-AM) or inhibiting calcineurin (CsA/FK506) mimics the Coro1A KO phenotype, reducing TGF-$\beta$RI stability.

D. SUMO-Dependent Stability of Coro1A

• SUMO Interaction: Coro1A itself is not SUMOylated but interacts with SUMOylated proteins via SUMO-Interacting Motifs (SIMs).
• Key Partner: Mass spectrometry and docking identified Raftlin (a lipid raft protein) as the SUMOylated partner.
  • Raftlin is SUMOylated at K31.
  • Coro1A binds to SUMOylated Raftlin via its SIM sites (specifically residues 155-159).
• Stability Mechanism: This Coro1A-SUMO-Raftlin interaction is essential for the stability of Coro1A protein. Disrupting the SIM site (V155K mutation) or reducing global SUMOylation (UBC9 knockdown) leads to rapid degradation of Coro1A.

4. Results Summary

1. SENP5 expression dynamics differ between CAC (up in inflammation, down in tumor) and SCRC (up in tumor).
2. Coro1A is a major SENP5 interactor in chronic inflammation, driving the accumulation of M2 macrophages.
3. Coro1A KO mice are protected from CAC, showing reduced fibrosis, EMT, and tumor burden.
4. Coro1A stabilizes TGF-$\beta$RI by preventing its lysosomal degradation via a calcium-calcineurin mechanism.
5. Coro1A stability is maintained by its interaction with SUMOylated Raftlin through SIM motifs.

5. Significance

• Novel Pathway: The study elucidates a previously unknown axis: SENP5 $\rightarrow$ SUMOylated Raftlin $\rightarrow$ Coro1A $\rightarrow$ TGF-$\beta$RI Stability $\rightarrow$ M2 Macrophage Polarization $\rightarrow$ CAC Tumorigenesis.
• Therapeutic Target: It identifies Coro1A and the SUMOylation machinery (specifically the Raftlin-Coro1A interaction) as potential therapeutic targets for preventing the progression of IBD to colorectal cancer.
• Differentiation from SCRC: It highlights that the molecular drivers of CAC (inflammation-driven) are distinct from SCRC (mutation-driven), particularly regarding the role of SENP5 and immune cell-mediated TME reprogramming.
• Mechanistic Insight: It provides a clear mechanism for how immune cells (macrophages) stabilize TGF-$\beta$ signaling to create an immunosuppressive, pro-fibrotic, and pro-tumorigenic niche in the gut.

In conclusion, this paper demonstrates that Coronin1A is a critical, SUMO-dependent regulator that stabilizes TGF-$\beta$ signaling endosomes in macrophages, thereby promoting M2 polarization and facilitating the transition from chronic colitis to colorectal cancer.